Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Bozena Dworecka Kaszak

Bozena Dworecka Kaszak

Warsaw University of Life Sciences-SGGW Poland

Yasemin Oz

Yasemin Oz

Tertiary university hospital. Turkey

Nojod Ahmed Alzumay

Nojod Ahmed Alzumay

University of Jeddah Saudi Arabia

Ali Rezaei-Matehkolaei

Ali Rezaei-Matehkolaei

Ahvaz Jundishapur University of Medical Sciences Iran

Mala V. Kaneria

Mala V. Kaneria

Kasturba Hospital for Infectious Diseases,Mumbai India

Saif Hameed

Saif Hameed

Amity University Haryana India

Mehdi Tavalla

Mehdi Tavalla

Ahvaz JundishapurUniversity of Medical Sciences Iran

Jasem Saki

Jasem Saki

Ahvaz Jundishapur University of Medical Sciences, Ahvaz Iran

Fungal Infections 2017

About Conference


ConferenceSeries Ltd is a renowned organization that organizes highly notable Microbiology and Infectious Diseases conferences throughout the globe. After a successful series of conferences, ConferenceSeries Ltd is currently bringing forth the "International Conference on Fungal Diseases and Control" (Fungal Infections 2017) held during December 04-05, 2017 at Dubai, UAE.

ConferenceSeries Ltd Organizes 1000+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board members.

Fungal Infections 2017 conference will focus on the latest and exciting innovations in all areas of fungal diseases research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. This year’s annual congress highlights the theme, “Update on current trends and developments in controlling fungal diseases” which reflects the innovative progress in fungal disease research. The two days conference includes workshops, symposiums, special keynote sessions conducted by eminent and renowned speakers who excel in the field of fungal diseases. This National Fungal Infections Conference also encourages the active participation of young student researchers as we are hosting Poster Award Competition and Young research Forum at the conference venue.

Take advantage of opportunities to learn about fungal diseases and control research from a variety of oral and poster presentations. Meet and network with Mycologists ranging from students to deans, faculty, and researchers. Take advantage of opportunities to collaborate with Mycologists from around the world. Attend prominent plenary sessions about relevant issues affecting nursing education.

Who can attend?

Fungal Diseases conference brings together individuals who have an interest in different fields of Fungal Infections. It is a forum to explore issues of mutual concern as well as exchange knowledge, share evidence, ideas, and generate solutions.

Why to Attend?

Fungal infections conferences provides a global platform for exchanging ideas and make us updated about the latest innovations in Fungal Diseases and Control.  Opportunity to attend the presentations delivered by Eminent Scientists from all over the world

Sessions/Tracks

FUNGAL DISEASE: About fifty fungal species cause human disease, usually by one of three major mechanisms. First, some fungi cause an immune response, resulting in hypersensitivity (allergic) reactions to the fungi. (The fungi themselves thus act as antigens .) For example, several Aspergillus species can cause asthma and other allergic reactions. The second mechanism is found in fungal species producing poisons or mycotoxins. Aspsergillus flavus grows on improperly stored grain and can produce aflatotoxins that cause tumors in birds and various other animals.

The third disease mechanism is infection. Mycoses (singular, mycosis) are fungal infections found in or on the body. Most mycoses are "nuisance" diseases, although some can be quite serious or even life-threatening. Many of the mycoses are caused by opportunistic organisms, organisms taking advantage of the patient whose defense mechanisms are down (such as persons suffering from AIDS [acquired immunodeficiency syndrome] ). Examples of opportunistic mycoses include histoplasmosis (usually respiratory), Cryptococcus’s (affecting any organ, often the brain), coccidioidomycosis (often respiratory), and candidiasis (the common yeast infection affecting any part of the body). (Candidiasis in the mouth and throat of newborns is called thrush.).

Related Conference :  5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs June 19-20, 2017 London, UK .3rd Annual Congress on Infectious Diseases  August 21-23, 2017 San Francisco, California, USA.7th Asia Pacific STD and Infectious Diseases Congress October 23-25, 2017 Osaka, Japan.6thEuro-Global Conference on Infectious Diseases  September 7-9, 2017 Paris, France.3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, USA.Singapore international infectious diseases conference SIIDC  on 24th to 26th August 2017 in Singapore.18th ICID International conference on Global infectious Diseases macro to micro.4rth international conference on prevention & infection control 20th -23rd  june Guneva,switxer land.27th European Congress of Clinical Microbiology and Infectious Diseases  22nd - 25th April 2017 Vienna, Austria.STI & HIV WORLD CONGRESS JULY9-12, 2017 RIO DE JANERIO- BRAZIL.

TYPES OF FUNGAL INFECTION:

Fungi (singular is fungus) are primitive organisms that live in and on air, water, soil, and other surfaces. Some types of fungus reproduce by sending tiny spores through the air. People who have a weakened immune system and those who are taking certain medicines (e.g., antibiotics, corticosteroids) are at increased risk for fungal skin infections.There are many different types of fungal infections. Common types include the following:

Athletes foot (tinea  pedis)

Ring warm (tinea corporis)

Tinea capitis

Onychomycosis

Tinea versicolor

Cutaneous candidiasis

Related Conference :  5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs June 19-20, 2017 London, UK .3rd Annual Congress on Infectious Diseases  August 21-23, 2017 San Francisco, California, USA.7th Asia Pacific STD and Infectious Diseases Congress October 23-25, 2017 Osaka, Japan.6thEuro-Global Conference on Infectious Diseases  September 7-9, 2017 Paris, France.3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, USA.Singapore international infectious diseases conference SIIDC  on 24th to 26th August 2017 in Singapore.18th ICID International conference on Global infectious Diseases macro to micro.4rth international conference on prevention & infection control 20th -23rd  june Guneva,switxer land.27th European Congress of Clinical Microbiology and Infectious Diseases  22nd - 25th April 2017 Vienna, Austria.STI & HIV WORLD CONGRESS JULY9-12, 2017 RIO DE JANERIO- BRAZIL.

PATHOGENICITY AND VIRULENCE:

Pathogenicity was defined as the capacity of a microbe to cause damage in a host . Pathogenic fungi are fungi that cause disease in humans or other organisms. The study of pathogenic fungi is referred to as "medical mycology." Although fungi are eukaryotic organisms, many pathogenic fungi are also microorganisms,

while virulence is viewed to be a relative term and defined as the relative capacity of a microbe to cause damage in a host. Specific pathogens possess a wide array of virulence factors. Some are chromosomally encoded and intrinsic to the bacteria (e.g. capsules and endotoxin), whereas others are obtained from mobile genetic elements like plasmids and bacteriophages (e.g. some exotoxins). Virulence factors encoded on mobile genetic elements spread through horizontal gene transfer, and can convert harmless bacteria into dangerous pathogens.

Related Conference :  5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs June 19-20, 2017 London, UK .3rd Annual Congress on Infectious Diseases  August 21-23, 2017 San Francisco, California, USA.7th Asia Pacific STD and Infectious Diseases Congress October 23-25, 2017 Osaka, Japan.6thEuro-Global Conference on Infectious Diseases  September 7-9, 2017 Paris, France.3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, USA.Singapore international infectious diseases conference SIIDC  on 24th to 26th August 2017 in Singapore.18th ICID International conference on Global infectious Diseases macro to micro.4rth international conference on prevention & infection control 20th -23rd  june Guneva,switxer land.27th European Congress of Clinical Microbiology and Infectious Diseases  22nd - 25th April 2017 Vienna, Austria.STI & HIV WORLD CONGRESS JULY9-12, 2017 RIO DE JANERIO- BRAZIL.

PHARMACEUTICAL MYCOLOGY:

Mycology is the branch of biology concerned with the study of fungi, including their genetic and biochemical properties, their taxonomy and their use to humans as a source for tinder, medicine, food, and entheogens, as well as their dangers, such as poisoning or infection. A biologist specializing in mycology is called a mycologist.

From mycology arose the field of phytopathology, the study of plant diseases, and the two disciplines remain closely related because the vast majority of "plant" pathogens are fungi.

Many fungi produce toxins, antibiotics, and other secondary metabolites. For example, the cosmopolitan (worldwide) genus Fusarium and their toxins associated with fatal outbreaks of alimentary toxic aleukia in humans were extensively studied by Abraham Joffe.

Related Conference :  5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs June 19-20, 2017 London, UK .3rd Annual Congress on Infectious Diseases  August 21-23, 2017 San Francisco, California, USA.7th Asia Pacific STD and Infectious Diseases Congress October 23-25, 2017 Osaka, Japan.6thEuro-Global Conference on Infectious Diseases  September 7-9, 2017 Paris, France.3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, USA.Singapore international infectious diseases conference SIIDC  on 24th to 26th August 2017 in Singapore.18th ICID International conference on Global infectious Diseases macro to micro.4rth international conference on prevention & infection control 20th -23rd  june Guneva,switxer land.27th European Congress of Clinical Microbiology and Infectious Diseases  22nd - 25th April 2017 Vienna, Austria.STI & HIV WORLD CONGRESS JULY9-12, 2017 RIO DE JANERIO- BRAZIL.

ANTIFUNGAL THERAPEUTICS:

Antifungal drugs are used to treat infections caused by fungus and to prevent the development of fungal infections in patients with weakened immune systems.

There are three classes of drugs typically used to treat fungal infections: polyenes, azoles, and echinocandins.

Polyenes:

polyenes’ are drugs that work by attaching to the sterol component found in the fungal membrane, causing the cells to become porous and die. The two polyenes most commonly used are nystatin (Mycostatin) and amphotericin B (Fungizone). Nystatin is often used as a topical agent to treat superficial infections, or is taken orally to treat candidal infections such as oral or esophageal candidiasis.

Amphotericin B was the first antifungal drug to be approved for use, and it is still the standard therapy for the most severe systemic fungal infections. Recently, several new types of amphotericin B (Abelcet, Amphotec and AmBisome) have been introduced. These drugs, called lipid formulations, cause fewer side effects than traditional amphotericin B but are more expensive.

Azoles:

Azoles stop fungal growth by preventing fungi from making an essential part of their cell wall. Three typical azoles are ketoconazole (Nizoral), fluconazole (Diflucan), and itraconazole (Sporanox). Ketoconazole is the oldest of these three drugs, and has been used since the 1970s. It is slightly more toxic than the other azoles and does not work for aspergillosis and many candidiasis infections.

Although fluconazole is effective against both superficial and systemic candidiasis, some strains of this fungus have now become resistant to the drug. Itraconazole, the newest of the azoles, is effective against a range of different fungal infections. Unlike ketoconazole or fluconazole, it can be used to treat aspergillosis.

Echinocandins:

Echinocandins are a new class of antifungal drugs that work by disrupting the wall that surrounds fungal cells. Caspofungin (Cancidas) is the first of this new class of drugs to be approved. It is an effective treatment for severe, systemic fungal infections, and is given to patients who do not respond to other therapies.

Related Conference :  5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs June 19-20, 2017 London, UK .3rd Annual Congress on Infectious Diseases  August 21-23, 2017 San Francisco, California, USA.7th Asia Pacific STD and Infectious Diseases Congress October 23-25, 2017 Osaka, Japan.6thEuro-Global Conference on Infectious Diseases  September 7-9, 2017 Paris, France.3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, USA.Singapore international infectious diseases conference SIIDC  on 24th to 26th August 2017 in Singapore.18th ICID International conference on Global infectious Diseases macro to micro.4rth international conference on prevention & infection control 20th -23rd  june Guneva,switxer land.27th European Congress of Clinical Microbiology and Infectious Diseases  22nd - 25th April 2017 Vienna, Austria.STI & HIV WORLD CONGRESS JULY9-12, 2017 RIO DE JANERIO- BRAZIL.

IMMUNOGENETICS OF FUNGAL DISEASES:

Although invasive fungal diseases are often assumed to be the only form of fungal disease, fungi more commonly cause chronic disease in individuals with ostensibly normal immune systems, or allergic disease in those with hyperactive immune systems, such as atopic asthmatics. Invasive fungal diseases affect individuals with an underlying defect in the immune system and are rapid in onset with high mortality, whereas chronic and allergic diseases primarily affect individuals with normal immune systems and are long-term, even lifelong, conditions

Biomarker Of Fungal Infections

Immunogenetics OF Dermatophytosis

Immunology Of Erythema Nodosum Leprosum

Related Conference :  5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs June 19-20, 2017 London, UK .3rd Annual Congress on Infectious Diseases  August 21-23, 2017 San Francisco, California, USA.7th Asia Pacific STD and Infectious Diseases Congress October 23-25, 2017 Osaka, Japan.6thEuro-Global Conference on Infectious Diseases  September 7-9, 2017 Paris, France.3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, USA.Singapore international infectious diseases conference SIIDC  on 24th to 26th August 2017 in Singapore.18th ICID International conference on Global infectious Diseases macro to micro.4rth international conference on prevention & infection control 20th -23rd  june Guneva,switxer land.27th European Congress of Clinical Microbiology and Infectious Diseases  22nd - 25th April 2017 Vienna, Austria.STI & HIV WORLD CONGRESS JULY9-12, 2017 RIO DE JANERIO- BRAZIL.

OUTBREAKS AND INVESTIGATIONS:

Fungal outbreaks have been linked to a variety of sources, including exposure to disease-causing fungi in the natural environment or injections with contaminated medication. With systems in place for early identification for these types of events, CDC and partners can continue to track, test for, respond to, and better understand emerging fungal health threats.

Related Conference :  5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs June 19-20, 2017 London, UK .3rd Annual Congress on Infectious Diseases  August 21-23, 2017 San Francisco, California, USA.7th Asia Pacific STD and Infectious Diseases Congress October 23-25, 2017 Osaka, Japan.6thEuro-Global Conference on Infectious Diseases  September 7-9, 2017 Paris, France.3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, USA.Singapore international infectious diseases conference SIIDC  on 24th to 26th August 2017 in Singapore.18th ICID International conference on Global infectious Diseases macro to micro.4rth international conference on prevention & infection control 20th -23rd  june Guneva,switxer land.27th European Congress of Clinical Microbiology and Infectious Diseases  22nd - 25th April 2017 Vienna, Austria.STI & HIV WORLD CONGRESS JULY9-12, 2017 RIO DE JANERIO- BRAZIL.

CAUSES & SYMPTOMS OF FUNGUS:

Fungal diseases are usually caused by common fungi found in our environment, including       the soil, plants, trees, and even on our skin and other parts of the body. Symptoms of fungal infection depend on the type and location in the body. Fungal infections may be mild, manifesting as rashes or mild respiratory problems. However, some diseases caused by fungi may be severe and can cause serious complications and death.

common skin inflammation

Trichophyton rubrum

Malassezia

yeast infections

Related Conference :  5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs June 19-20, 2017 London, UK .3rd Annual Congress on Infectious Diseases  August 21-23, 2017 San Francisco, California, USA.7th Asia Pacific STD and Infectious Diseases Congress October 23-25, 2017 Osaka, Japan.6thEuro-Global Conference on Infectious Diseases  September 7-9, 2017 Paris, France.3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, USA.Singapore international infectious diseases conference SIIDC  on 24th to 26th August 2017 in Singapore.18th ICID International conference on Global infectious Diseases macro to micro.4rth international conference on prevention & infection control 20th -23rd  june Guneva,switxer land.27th European Congress of Clinical Microbiology and Infectious Diseases  22nd - 25th April 2017 Vienna, Austria.STI & HIV WORLD CONGRESS JULY9-12, 2017 RIO DE JANERIO- BRAZIL.

DIAGNOSIS OF FUNGAL INFECTION:

Most diagnoses of fungal infections of the skin can be made by physical examination, assisted by the use of a Wood's lamp, skin scrapings for microscopic examination, and fungal cultures. Dermatophyte infections are common at all ages, in both sexes, and they have a worldwide distribution. These infections include tinea capitis, tinea cruris, tinea pedis, tinea corporis, tinea manuum and tinea barbae. Tinea versicolor, caused by Malassezia furfur, and candidal infections are also common. 

Mucorales

Cultures of clinical specimens

Histopathology

Anti fungal therapy

Diagnosis of Dermatophytosis.

Related Conference :  5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs June 19-20, 2017 London, UK .3rd Annual Congress on Infectious Diseases  August 21-23, 2017 San Francisco, California, USA.7th Asia Pacific STD and Infectious Diseases Congress October 23-25, 2017 Osaka, Japan.6thEuro-Global Conference on Infectious Diseases  September 7-9, 2017 Paris, France.3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, USA.Singapore international infectious diseases conference SIIDC  on 24th to 26th August 2017 in Singapore.18th ICID International conference on Global infectious Diseases macro to micro.4rth international conference on prevention & infection control 20th -23rd  june Guneva,switxer land.27th European Congress of Clinical Microbiology and Infectious Diseases  22nd - 25th April 2017 Vienna, Austria.STI & HIV WORLD CONGRESS JULY9-12, 2017 RIO DE JANERIO- BRAZIL.

TREATMENT & PREVENTION OF FUNGAL INFECTION:

Antifungal Drugs Are Used To Treat Fungal Diseases. Depending On The Nature Of The Infection, A Topical Or Systemic Agent May Be Used.

Example Of Antifungals Include: Fluconazole Which Is The Basis Of Many Over-The-Counter Antifungal Treatments . Another Example Is Amphotericin B Which Is More Potent And Used In The Treatment Of The Most Severe Fungal Infections That Show Resistance To Other Forms Of Treatment And It Is Administered Intravenously.

Drugs To Treat Skin Infections Are The AzolesKetoconazoleItraconazoleTerbinafine Among Others.

Yeast Infections In The Vagina, Caused By Candida Albicans, Can Be Treated With Medicated Suppositories Such As Tioconazole And Pessaries Whereas Skin Yeast Infections Are Treated With Medicated Ointments.

Related Conference :  5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs June 19-20, 2017 London, UK .3rd Annual Congress on Infectious Diseases  August 21-23, 2017 San Francisco, California, USA.7th Asia Pacific STD and Infectious Diseases Congress October 23-25, 2017 Osaka, Japan.6thEuro-Global Conference on Infectious Diseases  September 7-9, 2017 Paris, France.3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, USA.Singapore international infectious diseases conference SIIDC  on 24th to 26th August 2017 in Singapore.18th ICID International conference on Global infectious Diseases macro to micro.4rth international conference on prevention & infection control 20th -23rd  june Guneva,switxer land.27th European Congress of Clinical Microbiology and Infectious Diseases  22nd - 25th April 2017 Vienna, Austria.STI & HIV WORLD CONGRESS JULY9-12, 2017 RIO DE JANERIO- BRAZIL.

VACCINATION OF FUNGAL INFECTION:

A global major concern is the emergence and spread of life-threatening invasive infections in immunocompromised patients, in which the opportunistic fungal infections have greatly increased in the last decades. The high mortality rates associated with these infections, which remain as high as 40%, are due to the limited therapeutic options and the emergence of drug-resistant fungi, but also due to the lack of efficient early diagnosis. Consequently, these facts led to the opinion that new approaches are needed to improve the outcome of these patients, such as immunopreventive strategies that could even be combined with standard antifungal treatment. In view of the proven effectiveness of various antibacterial and antiviral vaccines in preventing the respective diseases, several works have been developed to induce protective immunity against fungal infections as well. The better understanding of how the immune system works against fungal pathogens has made possible to explore immunomodulatory strategies that can protect both immunocompetent and immunocompromised hosts and generate memory. Recently, two fungal vaccines against Candida have advanced through clinical trials.

Related Conference :  5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs June 19-20, 2017 London, UK .3rd Annual Congress on Infectious Diseases  August 21-23, 2017 San Francisco, California, USA.7th Asia Pacific STD and Infectious Diseases Congress October 23-25, 2017 Osaka, Japan.6thEuro-Global Conference on Infectious Diseases  September 7-9, 2017 Paris, France.3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, USA.Singapore international infectious diseases conference SIIDC  on 24th to 26th August 2017 in Singapore.18th ICID International conference on Global infectious Diseases macro to micro.4rth international conference on prevention & infection control 20th -23rd  june Guneva,switxer land.27th European Congress of Clinical Microbiology and Infectious Diseases  22nd - 25th April 2017 Vienna, Austria.STI & HIV WORLD CONGRESS JULY9-12, 2017 RIO DE JANERIO- BRAZIL.

CASE REPORTS OF FUNGAL DISEASES:

The use of medical cases in the problem-based learning approach has been increasing in medical schools worldwide.The use of medical cases has become a powerful tool for education using the problem-based learning (PBL) approach . PBL has been incorporated in the curriculum of many medical schools in several parts of the world, especially in the United States . The PBL approach in medical education promotes learning by confronting clinical problems . Thus, medical students and physicians in training and practice around the world have considered the step-by-step presentation and discussion of medical cases to be valuable from the educational point of view.

Case Report Of Fungal Infections

Allergic Reactions

Toxin Production

Opportunistic Fungal Infections, Diagnostic Methods

Related Conference :  5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs June 19-20, 2017 London, UK .3rd Annual Congress on Infectious Diseases  August 21-23, 2017 San Francisco, California, USA.7th Asia Pacific STD and Infectious Diseases Congress October 23-25, 2017 Osaka, Japan.6thEuro-Global Conference on Infectious Diseases  September 7-9, 2017 Paris, France.3rd International Conference on Flu and Emerging Infectious Diseases November 06-07, 2017 Las Vegas, USA.Singapore international infectious diseases conference SIIDC  on 24th to 26th August 2017 in Singapore.18th ICID International conference on Global infectious Diseases macro to micro.4rth international conference on prevention & infection control 20th -23rd  june Guneva,switxer land.27th European Congress of Clinical Microbiology and Infectious Diseases  22nd - 25th April 2017 Vienna, Austria.STI & HIV WORLD CONGRESS JULY9-12, 2017 RIO DE JANERIO- BRAZIL.

Market Analysis Report

Importance & Scope:

In the new bio-economy, fungi play a very important role in addressing major global challenges, being instrumental for improved resource efficiency, making renewable substitutes for products from fossil resources, upgrading waste streams to valuable food and feed ingredients, counteracting life-style diseases and antibiotic resistance through strengthening the gut biota, making crop plants more robust to survive climate change conditions, and functioning as host organisms for production of new biological drugs.

This range of new uses of fungi and control of diseases all stand on the shoulders of the efforts of mycologists over generations: the scientific discipline mycology has built comprehensive understanding within fungal biodiversity, classification, evolution, genetics, physiology, ecology, pathogenesis, and nutrition. Fungal Infections and its control could not make progress without this platform. To unfold the full potentials of what fungi can do for both environment and man we need to strengthen the field of mycology on a global scale.

 Fungal-2017 aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Fungal. It also provides the chance for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the fields of Fungal.

Fungal-2017 is an international platform for presenting research about diagnosis, prevention and management of pediatric diseases, exchanging ideas about it and thus, contributes to the dissemination of knowledge in Fungal for the benefit of both the academia and business. This event brings all the eminent researchers and experts in the field of Fungal  medicine to explore the advancements in the prevention and management of Fungal diseases. We bring together industrial executives ,Fungal  Parma and Health care sectors making the conference a perfect platform to network, share views and knowledge through interactive discussions.

Why UAE ?

Fungi are widespread in the environment so it is not unusual that a large amount of fungi and their spores end up being inhaled into the lungs or landing on the skin. Under conditions of moisture, warmth, irritation and injury these fungi grow rapidly and may cause infection.

Fungal infections of the skin that usually result in red, flaky patches on the skin cause physical stress and lead to mental distress. The hot, humid weather of the UAE is the ideal breeding ground for these infections and it is advisable to take precautionary actions.

Fungal infections of the skin, hair, and nails are a common public health problem worldwide. However, a population-based survey reported that they are rarely managed . The prevalence of skin fungal infections is expected to reach 20–25% and toe nails infection ,candida and other fungal infection are to be expected to reach 70-85% of the world's were as in USA 30-60% and in UAE 35-40%.

Statistics of fungal infection:

Globally, over 300 million people are afflicted with a serious fungal infection and 25 milllion are at high risk of dying or losing their sight. Estimates for the global burden of fungal diseases are based on population and disease demographics (age, gender, HIV infected, asthma etc)1. Some fungal diseases are acute and severe (i.e. cryptococcal meningitis and fungal eye infection (keratitis), other recurrent (i.e. Candida vaginitis or oral candidiasis in AIDS) and other chronic (i.e. chronic pulmonary aspergillosis or fungal hair infection (tinea capitis). 

Among the fungal infections, showed a higher prevalence (16,035,399 cases) than the other superficial mycoses (794,847 cases) between the years 2006 and 2016.

Estimation of  infected people in different age:

Universities in UAE :

1.Gulf Medical University
2.Ras al-Khaimah Medical and Health Sciences University
3.Dubai Medical College
4.College Of Medicine and Health Sciences
5.United Arab Emirates University
6.American University of Sharjah
7.University of Sharjah
8.Masdar Institute of Science and Technology
9.Abu Dhabi University
10.Dubai Pharmacy College

Hospitals in UAE:

Zulekha Hospital Sharjah
Emirates Hospital
Dubai Hospital (Govt)
Rashid Hospital (Govt)
Medcare Hospital
Canadian Specialist Hospital
Cosmolaser Medical Center
Al Zahra Hospital Sharjah
University Hospital Sharjah
Al Amanah Medical Center
Sunny Medical Centre LLC, Shahba
New Sunny Medical Centre LLC, Rolla
Al Salam Medical Center
Dr Fatima Nooh Medical Center LLC
Aster Medical Centre – Sharjah
Marina Medical Centre – Sharjah

Pharmaceutical companies in UAE :

Global Pharma
Pharmatrade L.L.C
Boehringer Ingelheim
Al Hayat Pharmaceuticals Company
Medpharma
Life Pharma FZE
Gulf Pharmaceutical Industries 
Mylan
Clinart International
Pharmaworld LLC
 

 

Past Conference Report

Bacteriology 2016

The 4th International Congress on Bacteriology and Infectious Diseases hosted by Conference Series LLC was successfully held during May 16-18, 2016, 2016 at San Antonio, Texas, USA. The conference was marked with the presence of Editorial Board Members of supported Conference Series LLC Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference successful and productive.

This conference highlighted the theme “Action on Infection: Fostering Medical and Industrial Microbiology Research” with the following scientific tracks:

  • Bacterial Morphology and Metabolism
  • Bacterial Clinical Studies
  • Bacterial Identification Methods
  • Emerging Infectious Diseases
  • Bacterial Pathogenesis
  • Plant Microbe Pathology
  • Veterinary Bacteriology
  • Natural Microbial Defenses and Immunity
  • Multi Pathogen Infections
  • Microbial Genomics
  • Industrial and Applied Bacteriology
  • Medical Microbiology
  • Advances in Antimicrobial Vaccines
  • Market Analysis and Manufactures
  • Entrepreneurs Investment Meet

We are thankful to our below Honorable guests: Kei Amemiya from US Army Medical Research Institute for Infectious Diseases, USA and Steven R Blanke from University of Illinois, USA, for their generous support and suggestions.

The conference proceedings were carried out through various Scientific Sessions and plenary lectures, of which the following were highlighted as Keynote presentations:

  • Title: Extending the gut-brain axis: The curious case of Helicobacter pylori

Steven R Blanke, University of Illinois, USA

  • Title: The vaginal microbiome during pregnancy, what do we know?

George L Mendz, The University of Notre Dame, Australia

  • Title: New non-synthetic antibacterial agents challenging the active and persistent forms of Borrelia ssp.

Anna Goc, Dr. Rath Research Institute BV, USA

  • Title: Host-pathogen interactions by clinical strains of Burkholderia pseudomallei in a murine model of Melioidosis

Kei Amemiya, US Army Medical Research Institute of Infectious Diseases, USA

Various sessions were chaired and co-chaired by:

  • George L Mendz, The University of Notre Dame, Australia
  • Steven R Blanke, University of Illinois, USA
  • Kei Amemiya, US Army Medical Research Institute for Infectious Diseases
  • Mohamed Fakhr, University of Tulsa, USA

Conference Series LLC has taken the privilege of felicitating Bacteriology 2016 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date December 04-05, 2017

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Medical Mycology: Open Access Virology & Mycology Open Access Mycobacterial Diseases Open Access

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by